Breast cancer
Results
Phase 2
This trial looked at pertuzumab and trastuzumab with or without cyclophosphamide, for people over the age of 60 with breast cancer that has spread.
This trial was open for people to join between 2013 and 2016, and the research team published the results in 2018.
Recruitment start: 2 July 2013
Recruitment end: 10 May 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cameron
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
F Hoffmann-La Roche
NIHR Clinical Research Network: Cancer
Last reviewed: 18 Jun 2020
CRUK internal database number: 12876
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
